Department of Developmental and Cell Biology,
School of Biosciences,
Department of Developmental and Cell Biology, School of Biosciences
Preetha Anand has not added Biography.
If you are Preetha Anand and would like to personalize this page please email our Author Liaison for assistance.
Interfacial properties as predictors of radioresistance in cervical cancer.
Journal of colloid and interface science Oct, 2007 | Pubmed ID: 17610888
Bioavailability of curcumin: problems and promises.
Molecular pharmaceutics Nov-Dec, 2007 | Pubmed ID: 17999464
Curcumin and cancer: an "old-age" disease with an "age-old" solution.
Cancer letters Aug, 2008 | Pubmed ID: 18462866
Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins.
Cancer letters Oct, 2008 | Pubmed ID: 18479807
Potential of spice-derived phytochemicals for cancer prevention.
Planta medica Oct, 2008 | Pubmed ID: 18612945
Cancer is a preventable disease that requires major lifestyle changes.
Pharmaceutical research Sep, 2008 | Pubmed ID: 18626751
Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature.
Biochemical pharmacology Dec, 2008 | Pubmed ID: 18775680
Coronarin D, a labdane diterpene, inhibits both constitutive and inducible nuclear factor-kappa B pathway activation, leading to potentiation of apoptosis, inhibition of invasion, and suppression of osteoclastogenesis.
Molecular cancer therapeutics Oct, 2008 | Pubmed ID: 18852134
Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells.
Blood Feb, 2009 | Pubmed ID: 18952893
Modification of cysteine residue in p65 subunit of nuclear factor-kappaB (NF-kappaB) by picroliv suppresses NF-kappaB-regulated gene products and potentiates apoptosis.
Cancer research Nov, 2008 | Pubmed ID: 18974130
Curcumin circumvents chemoresistance in vitro and potentiates the effect of thalidomide and bortezomib against human multiple myeloma in nude mice model.
Molecular cancer therapeutics Apr, 2009 | Pubmed ID: 19372569
Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model.
International journal of cancer. Journal international du cancer Nov, 2009 | Pubmed ID: 19623659
Design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo.
Biochemical pharmacology Feb, 2010 | Pubmed ID: 19735646
Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer.
International journal of cancer. Journal international du cancer Jul, 2010 | Pubmed ID: 19908231
Characterization and mechanistic studies of a novel melanoma-targeting construct containing IκBa for specific inhibition of nuclear factor-κB activity.
Neoplasia (New York, N.Y.) Oct, 2010 | Pubmed ID: 20927315
Suppression of pro-inflammatory and proliferative pathways by diferuloylmethane (curcumin) and its analogues dibenzoylmethane, dibenzoylpropane, and dibenzylideneacetone: role of Michael acceptors and Michael donors.
Biochemical pharmacology Dec, 2011 | Pubmed ID: 21924245
Mechanical stochastic tug-of-war models cannot explain bidirectional lipid-droplet transport.
Proceedings of the National Academy of Sciences of the United States of America Nov, 2011 | Pubmed ID: 22084076
Casein kinase 2 reverses tail-independent inactivation of kinesin-1.
Nature communications , 2012 | Pubmed ID: 22453827
JoVEについて
Copyright © 2023 MyJoVE Corporation. All rights reserved